NASDAQ:NLSP
NLS Pharmaceutics AG
- Stock
locale
Switzerlandmarket
STOCKSindustry
Biotechnologywebsite
nlspharma.comipo date
Jan 29, 2021
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactiv...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus